GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » FCF Yield %

Corix Bioscience (Corix Bioscience) FCF Yield % : 0.00 (As of Jun. 15, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Corix Bioscience's Trailing 12-Month Free Cash Flow is $-3.13 Mil, and Market Cap is $0.00 Mil. Therefore, Corix Bioscience's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Corix Bioscience's FCF Yield % or its related term are showing as below:


CXBS's FCF Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: -0.15
* Ranked among companies with meaningful FCF Yield % only.

Corix Bioscience's FCF Margin % for the quarter that ended in Sep. 2017 was 0.00%.


Corix Bioscience FCF Yield % Historical Data

The historical data trend for Corix Bioscience's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience FCF Yield % Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
FCF Yield %
Get a 7-Day Free Trial - -0.34 -2.60 - -19.58

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.71 -14.52 -16.54 -16.51 -29.51

Competitive Comparison of Corix Bioscience's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corix Bioscience's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's FCF Yield % falls into.



Corix Bioscience FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Corix Bioscience's FCF Yield % for the fiscal year that ended in Dec. 2016 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1.877 / 9.5851107
=-19.58%

Corix Bioscience's annualized FCF Yield % for the quarter that ended in Sep. 2017 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.722 * 4 / 23.338003
=-29.51%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Corix Bioscience FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Corix Bioscience FCF Yield % Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Corix Bioscience (Corix Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines